Defining the Value of Interventional Radiology to Healthcare Stakeholders: Proceedings from a Society of Interventional Radiology Research Consensus Panel.


Journal

Journal of vascular and interventional radiology : JVIR
ISSN: 1535-7732
Titre abrégé: J Vasc Interv Radiol
Pays: United States
ID NLM: 9203369

Informations de publication

Date de publication:
07 2021
Historique:
received: 25 09 2020
revised: 03 04 2021
accepted: 13 04 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 26 11 2021
Statut: ppublish

Résumé

Interventional radiology (IR) has collectively struggled to articulate and prove its value to several external stakeholders. The goal of this research consensus panel was to provide a summary of the existing knowledge, identify current gaps in knowledge, identify the strengths and weaknesses in existing data, and prioritize research needs related to the value of IR. Panelists were asked to identify the critical relationships/alliances that should be fostered to advance the prioritized research and determine how the Society of Interventional Radiology and the Society of Interventional Radiology Foundation can further support these initiatives. Following presentations and discussions, it was determined that proving and quantifying how IR decreases the length of stay and prevents hospital admissions are the most salient, value-related research topics to pursue for the specialty.

Identifiants

pubmed: 34210476
pii: S1051-0443(21)01026-5
doi: 10.1016/j.jvir.2021.04.011
pii:
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1088.e1-1088.e8

Informations de copyright

Copyright © 2021 SIR. Published by Elsevier Inc. All rights reserved.

Auteurs

C Matthew Hawkins (CM)

Department of Radiology and Imaging Sciences, Emory University School of Medicine Atlanta, Georgia; Division of Pediatric Radiology, Children's Pediatric Institute; Children's Healthcare of Atlanta, Atlanta, Georgia. Electronic address: Matt.hawkins@emory.edu.

Richard Duszak (R)

Department of Radiology and Imaging Sciences, Emory University School of Medicine Atlanta, Georgia.

Danny R Hughes (DR)

School of Economics, Health Economics and Analytics Lab, Georgia Institute of Technology, Atlanta, Georgia.

Ray Liu (R)

Department of Radiology, Massachusetts General, Boston, Massachusetts.

Andrew S Resnick (AS)

Department of Quality and Safety, Brigham and Women's Hospital, Boston, Massachusetts.

David A Kooby (DA)

Department of Surgery, Winship Cancer Institute, Emory University School of Medicine Atlanta, Georgia.

Jeremy C Durack (JC)

Division of Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.

John A Kaufman (JA)

Dotter Department of Interventional Radiology, Oregon Health and Science University, Portland, Oregon.

Frank Dubeck (F)

Change Healthcare, Inc., Nashville, Tennessee.

Mark B Canada (MB)

Radiology Associates of Richmond, Inc., Richmond, Virginia.

Katharine L Krol (KL)

SIR Foundation, Fairfax, Virginia.

Sarah B White (SB)

Division of Vascular and Interventional Radiology, Department of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH